Cited by 1,058Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCancer Genomics and Diagnostics

The DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.

Natural selection of tumor variants in the generation of “tumor escape” phenotypes

Open access

Khong, Hung T., Restifo, Nicholas P.·2002·Nature Immunology

Open this paper in CoChat — free account

Abstract

The idea that tumors must "escape" from immune recognition contains the implicit assumption that tumors can be destroyed by immune responses either spontaneously or as the result of immunotherapeutic intervention. Simply put, there is no need for tumor escape without immunological pressure. Here, we review evidence supporting the immune escape hypothesis and critically explore the mechanisms that may allow such escape to occur. We discuss the idea that the central engine for generating immunoresistant tumor cell variants is the genomic instability and dysregulation that is characteristic of the transformed genome. "Natural selection" of heterogeneous tumor cells results in the survival and proliferation of variants that happen to possess genetic and epigenetic traits that facilitate their growth and immune evasion. Tumor escape variants are likely to emerge after treatment with increasingly effective immunotherapies.

Integrity signals

Registry

Crossref · 10.1038/ni1102-999

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J., Lanier, L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 3,272
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Inhibition of death receptor signals by cellular FLIP
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.-L., Schröter, M., Burns, K., Mattmann, C., et al. (1997) · Nature · doi:10.1038/40657 · Cited by 2,548
A cell culture model for T lymphocyte clonal anergy
Schwartz, R. H. (1990) · Science · doi:10.1126/science.2113314 · Cited by 1,857
Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance
Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y., & Sakaguchi, S. (2002) · Nature Immunology · doi:10.1038/ni759 · Cited by 1,729
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance
Sakaguchi, S., Sakaguchi, N., Shimizu, J., Yamazaki, S., Sakihama, T., Itoh, M., Kuniyasu, Y., Nomura, T., Toda, M., & Takahashi, T. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820102.x · Cited by 1,505
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
CD4+CD25+ Immunoregulatory T Cells
McHugh, R. S., Whitters, M. J., Piccirillo, C. A., Young, D. A., Shevach, E. M., Collins, M., & Byrne, M. C. (2002) · Immunity · doi:10.1016/s1074-7613(02)00280-7 · Cited by 1,395
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P. J., Schreier, M. H., French, L. E., Schneider, P., Bornand, T., Fontana, A., Liénard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,236

Show all 104 references

Sorted by citations

Items 901–998 of 998

Epigenetic quantification of tumor-infiltrating T-lymphocytes in epithelial ovarian tumors
Vasconcelos, I. I. M. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-6760
The Role of Tumor Suppressors, SHIP and Rb, in Immune Suppressive Cells
Ruiz, C. G., & Marie, M. (2012)
Modulação da resposta imune durante o desenvolvimento de carcinoma espinocelular
Belai, E. B. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.25.2011.tde-18012012-143731
Immune responses to tumours: current concepts and applications
Soilleux, E. J. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545955.008
Estudio de las alteraciones de linfocitos t de sangre periférica y de mucosa en pacientes con adenocarcinoma gástrico
Santalla, M. L. (2012) · Dialnet (Universidad de la Rioja)
The role of D6 in neutrophil migration, melanoma growth and metastasis
Burt, C. L. (2011) · Enlighten: Theses (The University of Glasgow)
Preparation for a Clinical Trial Using Adoptive Transfer of Tumor-Reactive TGF_Beta-Insensitive CD8+ T Cells for Treatment of Prostate Cancer
Lee, C., Kuzel, T. M., Meagher, R., Yang, X. J., Smith, N. D., & Zhang, Q. (2006) · Defense Technical Information Center (DTIC) · doi:10.21236/ada462885
Mecanismos da toxidez de FGF2 em células malignas dependentes de Ras: bloqueio de divisão celular e estresse proteotóxico
Dias, M. H. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2012.tde-24052013-093639
On the role of innate cell interactions in inflammation and leukemia
Riise, R. E. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Effects of intracellular and extracellular heat shock proteins on anti-tumor immune responses
Milani, V. (2005) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.3369
Enhancing Adoptive Cell Transfer for the Treatment of Cancer
Shields, N. J. (2014) · Otago University Research Archive (University of Otago)
The effects of host response and vaccine design on early signaling profiles of MUC1-specific T cells
Reichenbach, D. K. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Rekombinante Antikörper-Enzym-Fusionskonstrukte zur zielgerichteten Therapie kolorektaler Karzinome
Deckert, P. M. (2010) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-5701
Tumor-Reactive T-Cells for Adoptive Immunotherapy
Bernhard, H., Neudorfer, J., Gebhard, K., Conrad, H., Busch, D. H., & Peschel, C. (2006) · Humana Press eBooks · doi:10.1385/1-59745-011-1:167
Promises and Challenges with Immunomodulatory Biologics
Ponce, R. A. (2014) · Wiley eBooks · doi:10.1002/9783527676965.ch8
Análise do envolvimento do receptor de quimiocinas - CCR5 - na migração de células T reguladoras: correlação com o desenvolvimento de carcinoma espinocelular
de Oliveira, C. E. (2013) · doi:10.11606/t.25.2013.tde-14102013-170536
Role of CYBR, a cytohesin binder and regulator scaffold protein, in cell-mediated immune response in vivo
Frenati, M. (2013) · Padua Research Archive (University of Padova)
Features of the immune proteasome expression in ascite Zajdela hepatoma after implantation into Brattleboro rats with the hereditary defect of arginine-vasopressin synthesis
Melnikova, V. I., Хегай, И. И., Попова, Н. А., Лифанцева, Н. В., Ivanova, L. N., & Захарова, Л. А. (2014) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162014060107
La detección antígeno-específica de linfocitos T y sus aplicaciones clínicas
Kalergis, A. M., Fierro, A., Claudio Figueroa, G., González, P. A., & Tobar, J. A. (2004) · Revista médica de Chile · doi:10.4067/s0034-98872004000300014
Restoration of expression of MHC class I molecule in Walker 256 tumor in growth dynamics in Brattleboro rats
Afanasyeva, M. A., Захарова, Л. А., Хегай, И. И., Sharova, N. P., Попова, Н. А., Ivanova, L. N., & Melnikova, V. I. (2010) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672910010047
Antiangiogenic cancer therapy using peptide vaccine for patients with advanced pancreatic cancer
Miyazawa, M., & Yamaue, H. (2010) · Suizo · doi:10.2958/suizo.25.53
Translational Research in Melanoma
Ray, M., Farma, J. M., & Hsu, C. (2013) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2013.06.009
Tumor-Induced Immune Dysfunction: Mechanism and Therapeutic Strategies
Hanson, M. (2007) · Figshare
Immunology of Inflammatory Breast Cancer
Reuben, J. M., & Lee, B.-N. (2012) · Springer eBooks · doi:10.1007/978-94-007-3907-9_17
MOLECULAR PROFILING OF UROTHELIAL CARCINOMA
Lindgren, D. (2006) · Lund University Publications (Lund University)
TRIGGERING AND MECHANISMS OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY
Bryceson, Y. T. (2008) · Figshare
Distal Tumors Elicit Distinctive Gene Expression Changes in Mouse Brain, Different from Those Induced by Arthritis
Alvarez, M. J., Salibe, M., Stolovitzky, G. A., Rubinstein, M., Pitossi, F. J., & Podhajcer, O. L. (2009) · The Open Neuroscience Journal · doi:10.2174/1874082000903010013
Lymphocytes genetically modified to express tumor antigens target dendritic cells in vivo and induce antitumor immunity
Cipponi, A. (2008) · DSpaceUnipr (University of Parma)
Dendritic Cells for Cancer Immunotherapy
Larmonier, N., & Katsanis, E. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-417-3_11
Immunotherapy of Cancer: Towards a New Era
Haanen, J. B. A. G. (2014) · EMJ Oncology · doi:10.33590/emjoncol/10310669
Cancer immunotherapeutics: raising the ante.
Thorat, M. A., Datar, R. H., & Joshi, N. N. (2006) · PubMed
Estudo da resposta imunológica desencadeada por células de cancro de bexiga que expressam antigénios sialil-Tn
Vida, D. D. C. D. (2010)
Multilevel omic data integration in cancer cell lines: advanced annotation and emergent
Devescovi, V., Chen, S., & Nardini, C. (2013)
Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D. I., & Sotomayor, E. M. (2007)
Critical appraisal of the current status of dendritic cell based therapy
Tirapu, I., Huarte, E., Alfaro, C., Arina, A., Murillo, O., Inogés, S., Bendandi, M., Mazzolini, G. D., & Melero, I. (2005)
Tumorassoziierte T-Lymphozyten: Phänotypische und funktionelle Eigenheiten in Gesunden und in Tumorpatienten
Attig, S. (2009)
Overview of MHC Class I Antigens
Aptsiauri, N., Garcia-Lora, A. M., & Cabrera, T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6543-0_1
Dendritic Cell-Based Cancer Immunotherapy: Achievements and Novel Concepts
Bol, K. F., Schreibelt, G., Aarntzen, E. H. J. G., de Vries, I. J. M., & Figdor, C. G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4732-0_4
Expressão da molecula do MHC classe I pelo tumor de Walker 256 durante sua conversão de variante A (agressiva) em variante AR (regressiva)
Schanoski, A. S. (2004) · doi:10.47749/t/unicamp.2004.302667
The role of myeloid cells in breast cancer metastasis
Swierczak, A. (2012) · Minerva Access (University of Melbourne)
Molecular Immunotherapeutics and Vaccines for Renal Cell Carcinoma and Its Vasculature
Chi-Sabins, N., Taylor, J. L., Lowe, D. B., & Storkus, W. J. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1419-3_22
La inestabilitat cromosòmica en el càncer colorectal
Camps, J. (2005) · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona)
Tumor-Induced Immune Suppression and Immune Escape
Campoli, M. R., & Ferrone, S. (2006) · Humana Press eBooks · doi:10.1385/1-59745-011-1:263
SA-4-1BBL as a modulator of T effector to T regulatory cell conversion.
Madireddi, S. (2010) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/880
Comorbid Development of Infection and Cancer
Ismail, N., Shurin, M. R., & Zaghloul, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-20669-1_15
Two novel mechanisms of MHC class I down-regulation in human cancer: accelerated degradation of TAP-1 mRNA and disruption of TAP-1 protein function
Yang, T. (2004) · OhioLink ETD Center (Ohio Library and Information Network)
Challenges of Adoptive (T-)cell Transfer Immunotherapy for Cancer
Volk, A. (2016)
Attenuation of Immune Suppression to Complement Glioma Immunotherapy
Field, C. S. (2016) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17013761 · Cited by 1
Immuntherapie von autochthonen gastrointestinalen Tumoren mit dendritischen Zellen und CpG-Oligonukleotiden
der Abteilung, A., Endres, S., & München, L.-M.-U. (2009)
Role and prognostic importance of regulatory T cells in lung cancer patients, according to the presence of tertiary lymphoid structures
Devi-Marulkar, P. (2015) · theses.fr (ABES) · doi:10.70675/1afef94czc6daz4936zb0d3z44f75d1762b1
T-Cell Stimulation by Melanoma RNA-Pulsed Dendritic Cells
München, L.-M.-U. (2004)
[Current topics and future to vaccine for pancreatic cancer].
Miyazawa, M., & 裕機, 山. (2013) · Nippon Jibiinkoka Gakkai Kaiho · doi:10.3950/jibiinkoka.116.573
Genotyping of Human Leukocyte Antigen (HLA) Ancestral Haplotypes as Prognostic Marker in Cancer Using PCR Analysis
Villabona, L. E. E., Andersson, E. K., Marchesi, M., & Masucci, G. V. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-727-3_18
The role and significance of STAT3 molecule and human mesenchymal stem cells in experimental model of mammary carcinoma
Ljujić, B. (2013) · doi:10.2298/kg20131014ljujic
Ferritin Expression in Breast Cancer Infiltrating Lymphocytes. Evaluation of Biological Significance and Modulation by HLA-A*03 and HFE
Leite, L. R. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/v3x7-ys11
Cellular and molecular events controlling acquisition of cytotoxic activity by melanoma-reactive CD4⁺ T cells in vivo
Bergerhoff, K. F. (2016) · UCL Discovery (University College London)
Evolution and Clinical Significance of the α-Gal Epitope
Galili, U. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00149-5
Dendritic Cell Vaccines for Gliomas
Luptrawan, A., Liu, G., Brian, S., & Yu, J. S. (2008) · Translational medicine series · doi:10.3109/9781420054682.005
Immune-Based Targeting in Cancer
Irvin, D. K., Patil, C. G., & Black, K. L. (2013) · CRC Press eBooks · doi:10.1201/b15274-11
Carbohydrate derived nanoplatforms as tools for lectin isolation, and delivery of cytotoxic T-cell peptide epitopes for cytotoxic T- cell mediated tumor immunotherapy
Kavunja, H. W. (2015) · doi:10.25335/8t23-gc56
Progressive multifocal leukoencephalopathy, a possible complication in a patient with bladder cancer
Latifyan, S., Sideris, S., Papaleo, A., Divano, L., Malarme, M., Georgala, A., & Bels, D. D. (2015) · Clinical Case Reports and Reviews · doi:10.15761/ccrr.1000175
Investigating the role of the PD-1 pathway in human ovarian cancer
Maine, C. J. (2010) · doi:10.25560/5578
Researchpromoting effects of CD95 signaling in chemoresistant cells
Ametller, E., García‐Recio, S., Costamagna, D., Mayordomo, C., Fernández, P. L., Carbó, N., Pastor‐Arroyo, E. M., Gascón, P., & Almendro, V. (2010)
Improvement of Salmonella vaccine strains for cancer immune therapy based on secretion or surface display of antigens Verbesserung von Salmonella Vakzinstämmen zur Krebsimmuntherapie basierend auf Sekretion oder oberflächenassoziierter Expression von
Hotz, C. (2008)
Role of Nitric Oxide-Signalling in Hypoxia-Induced Immune Escape in Cancer
Hamilton, T. K. (2011) · QSpace (Queen's University Library)
Targeting Neuropilin-1 in Prostate Cancer Bone Metastasis
Wu, D. (2010) · Defense Technical Information Center (DTIC) · doi:10.21236/ada538180
Inmunoterapia contra el cáncer: ¿conducirá el aumento de los conocimientos al éxito en oncología pediátrica?
Fry, T. J., & Lankester, A. C. (2008) · Clínicas pediátricas de Norteamérica
Loss of Mismatched HLA in Acute Leukemia Pediatric Patients after a Haploidentical Hematopoietic Stem Cell Transplantation
Ono, S., Minakawa, K., Kawabata, K., Yasuda, H., Ikeda, K., Takahashi, N., Ohara, Y., Kobayashi, S., Mochizuki, K., Ito, M., et al. (2018) · Major Histocompatibility Complex · doi:10.12667/mhc.25.34
T cells in solid tumors : investigating the immunomodulation in the tumor microenvironment
Hartana, C. A. (2018) · Figshare
Is radiotherapy the missing link to enhancing the outcomes in non-small cell lung cancer patients treated with immunotherapy?
van Dams, R., Raben, D., & Lee, P. P. (2018) · Therapeutic Radiology and Oncology · doi:10.21037/tro.2018.12.08
IL-33 no carcinoma espinocelular de pele
Boas, V. G. V. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.25.2019.tde-14052019-180319
Pathogenese und genetischer Hintergrund des Osteosarkoms: Aktuelle Konzepte und Entwicklungen
Baumhoer, D. (2018) · Der Pathologe
[Safety and efficacy of patients with high risk and elevated minimal residual disease after allogeneic hematopoietic stem cell transplantation treated with interferon in combination with interleukin-2 regimen].
Ai, H., Yw, F., Wang, Q., Xd, W., & Yp, S. (2019) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2019.03.015
Immunotherapy in head and neck cancer: A review
Bhateja, S., Hassan, S. A., & Arora, G. (2020) · Journal of Oral Medicine Oral Surgery Oral Pathology and Oral Radiology · doi:10.18231/j.jooo.2020.008
Reprogrammed M1 macrophages with inhibited STAT3, STAT6 and/or SMAD3 extends lifespan of mice with experimental carcinoma
Валерьевич, К. С., Владимировна, Л. С., Раецкая, А. А., & Malyshev, I. Y. (2017) · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» · doi:10.25557/0031-2991.2017.02.4-9
Optical Metabolic Imaging to Characterize Early Treatment Response in Head and Neck Cancer
Shah, A. T. (2016)
Cancer Immunoediting in Gliomas: Recent Advances and Implications for Immunotherapy
Shah, P., Arrieta, V. A., Lee-Chang, C., & Sonabend, A. M. (2020) · Journal of Cellular Immunology · doi:10.33696/immunology.2.066 · Cited by 1
Utilizing nanotechnology to improve the activation of CD8 T cells for cancer immunotherapy
Kosmides, A. K. (2018)
The Effect of Necroptosis-related Gene Signature on the Progression, Prognosis, and Immune Microenvironment of Low-grade GliomaPreprint
Zeng, K., Zhang, G., Huang, W. Y., Zhang, J., & Chen, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-1156900/v1
The Immunology and Biology of Brain Tumors
Graner, M. W. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-0103-1
Role of Innate Immunity in Cancers and Antitumor Response
Jinushi, M., & Baghdadi, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_2
Cancer Vaccines
Giese, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-25832-4_12
HLA Class I
Aptsiauri, N., & Osuna, F. R.-C. (2017) · Springer eBooks · doi:10.1007/978-3-662-46875-3_2766
HLA Class I
Aptsiauri, N., & Osuna, F. R.-C. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_2766
Faculty Opinions recommendation of Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.
Brutkiewicz, R. R. (2004) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1019995.227458
HLA Class I
Aptsiauri, N., & Osuna, F. R.-C. (2008) · Springer eBooks · doi:10.1007/978-3-540-47648-1_2766
Selfish Evolution
Conti, M. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8642-7_3
Iron Nanoparticles as Magnetic Resonance Imaging Contrast Agents
Ferguson, P. M. (2011) · doi:10.26686/wgtn.17011418
HLA Class I
Aptsiauri, N., & Osuna, F. R.-C. (2015) · Springer eBooks · doi:10.1007/978-3-642-27841-9_2766-7
Cancer and Evolution: An Ancient Relation Explored Recently
Chatterjee, A. (2022) · International Journal of Research and Review · doi:10.52403/ijrr.20220736
Accurate Enumeration of Apoptotic Cancer Cells Using Flow Cytometry
Díaz, D., Barcenilla, H., I, A. P., Monserrat, J., & Álvarez‐Mon, M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2553-8_4
T-Cell Stimulation by Melanoma RNA-Pulsed Dendritic Cells
Javorovic, M. (2004) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.3056
Cancer Immunotherapy: A Brief History, The Latest Development of Typical Subtypes and Therapy Combination
Tan, S. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v30i.4943
Data from Tumor-Localized Ligation of CD3 and CD28 with Systemic Regulatory T-Cell Depletion Induces Potent Innate and Adaptive Antitumor Responses
Lee, C.-H., Chiang, Y.-H., Chang, S., Chong, C.-L., Cheng, B.-M., & Roffler, S. R. (2023) · doi:10.1158/1078-0432.c.6517468
Data from Allogeneic MHC Gene Transfer Enhances an Effective Antitumor Immunity in the Early Period of Autologous Hematopoietic Stem Cell Transplantation
Kobayashi, A., Hara, H., Ohashi, M., Nishimoto, T., Yoshida, K., Ohkohchi, N., Yoshida, T., & Aoki, K. (2023) · doi:10.1158/1078-0432.c.6518808
Data from Cancer-Testis Antigens and Immunosurveillance in Human Cutaneous Squamous Cell and Basal Cell Carcinomas
Walter, A., Barysch, M. J., Behnke, S., Dziunycz, P., Schmid, B., Ritter, E., Gnjatic, S., Kristiansen, G., Moch, H., Knuth, A. K., et al. (2023) · doi:10.1158/1078-0432.c.6518925
Data from Tumor-Localized Ligation of CD3 and CD28 with Systemic Regulatory T-Cell Depletion Induces Potent Innate and Adaptive Antitumor Responses
Lee, C.-H., Chiang, Y.-H., Chang, S., Chong, C.-L., Cheng, B.-M., & Roffler, S. R. (2023) · doi:10.1158/1078-0432.c.6517468.v1
Data from Development of Tumor-Reactive T Cells After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for Chronic Lymphocytic Leukemia
Nishida, T., Hudecek, M., Kostić, A., Bleakley, M., Warren, E. H., Maloney, D. G., Storb, R. F., & Riddell, S. R. (2023) · doi:10.1158/1078-0432.c.6517842.v1

Authors: Khong, H. T., & Restifo, N. P.
Affiliations: National Institutes of Health (US)
Corresponding author: Khong, Hung T.
Restifo, Nicholas P.
ORCID: Khong, Hung T.
Restifo, Nicholas P.
Venue: Nature Immunology
Publisher: Springer Science and Business Media LLC
Published: 2002-11
Volume: 3
Issue: 11
Pages: 999-1005
ISSN: 1529-2908 (ISSN-L)
1529-2916
DOI: 10.1038/ni1102-999
PMC: PMC1508168
OpenAlex: W2051940153
Cited by: 1,058
References: 104
Citations by year: 2026: 17 · 2025: 18 · 2024: 33 · 2023: 45 · 2022: 35 · 2021: 28 · 2020: 40 · 2019: 39 · 2018: 38 · 2017: 51 · 2016: 32 · 2015: 43 · 2014: 41 · 2013: 63 · 2012: 44
FWCI: 5.47
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Immunology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
University of Regensburg Publication Server (University of Regensburg)
Funders: National Institutes of Health (Z99 CA999999)
National Cancer Institute (Z01BC010763)
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords: tumor immune evasion, natural selection, tumor heterogeneity, tumor variants, genomic instability, immunoresistance, epigenetic regulation, cancer immunotherapy resistance, immune evasion
MeSH terms: Animals, Antigens, Neoplasm, HLA Antigens, Humans, Immunologic Surveillance, Immunotherapy, Killer Cells, Natural, Neoplasms, Selection, Genetic, T-Lymphocytes, Cytotoxic, Immunodominant Epitopes, Cytokines, Apoptosis, Models, Immunological, Disease Progression, Tumor Escape, T-Lymphocytes, Regulatory, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Natural selection of tumor variants in the generation of “tumor escape” phenotypes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks